Once-daily simeprevir (TMC435) with peginterferon/ribavirin in treatment-naive or treatment-experienced chronic HCV genotype 4-infected patients: final results of a phase III trial - Moreno, C; Hezode, C; Marcellin, P (Journal of Hepatology, 2014)
et al.